Andrew F Ducruet Selected Research

complement C3a receptor

10/2022	Complement C3a Receptor (C3aR) Mediates Vascular Dysfunction, Hippocampal Pathology, and Cognitive Impairment in a Mouse Model of VCID.
12/2019	The Role of Complement C3a Receptor in Stroke.
4/2019	C3a Receptor Inhibition Protects Brain Endothelial Cells Against Oxygen-glucose Deprivation/Reperfusion.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrew F Ducruet Research Topics

Disease

37	Stroke (Strokes) 01/2022 - 01/2006
25	Aneurysm (Aneurysms) 10/2022 - 05/2007
15	Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage) 10/2022 - 08/2007
14	Ischemic Stroke 12/2018 - 08/2009
13	Brain Ischemia (Cerebral Ischemia) 10/2022 - 07/2006
12	Intracranial Aneurysm (Cerebral Aneurysm) 04/2022 - 05/2007
9	Infarction (Infarctions) 01/2020 - 04/2006
8	Hemorrhage 11/2021 - 05/2007
7	Inflammation (Inflammations) 01/2021 - 01/2008
7	Cerebral Hemorrhage 03/2017 - 12/2007
6	Ischemia 04/2019 - 04/2006
6	Reperfusion Injury 12/2015 - 07/2006
5	Pathologic Constriction (Stenosis) 04/2022 - 04/2014
5	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2022 - 12/2007
5	Thrombosis (Thrombus) 01/2020 - 05/2007
4	Cognitive Dysfunction 10/2022 - 05/2009
4	Hematoma 02/2021 - 09/2010
4	Brain Injuries (Brain Injury) 01/2020 - 01/2008
3	Rupture 01/2020 - 01/2019
3	Brain Edema (Cerebral Edema) 01/2020 - 04/2010
3	Fistula 09/2017 - 03/2016
2	Ruptured Aneurysm 10/2022 - 11/2021
2	Chronic Subdural Hematoma 02/2021 - 12/2009
2	Hypertension (High Blood Pressure) 01/2021 - 04/2010
2	COVID-19 11/2020 - 11/2020
2	Carotid Stenosis (Carotid Artery Stenosis) 01/2020 - 01/2006
2	Wounds and Injuries (Trauma) 01/2020 - 06/2015
2	Neoplasms (Cancer) 01/2020 - 08/2016
2	Pica (Geophagia) 12/2019 - 12/2012
2	False Aneurysm (Pseudoaneurysm) 01/2019 - 02/2018
2	Inappropriate ADH Syndrome (SIADH) 01/2017 - 03/2016
2	Critical Illness (Critically Ill) 12/2015 - 07/2009
2	Pseudotumor Cerebri (Idiopathic Intracranial Hypertension) 04/2014 - 07/2013
2	Subdural Hematoma (Subdural Hemorrhage) 04/2012 - 12/2009
2	Edema (Dropsy) 01/2011 - 04/2010
1	Alzheimer Disease (Alzheimer's Disease) 10/2022
1	Atrophy 10/2022
1	Arteriovenous Malformations (Arteriovenous Malformation) 04/2022
1	Neuroblastoma 01/2022
1	Hydrocephalus (Hydrocephaly) 11/2021
1	Coronary Artery Disease (Coronary Atherosclerosis) 01/2021
1	Optic Nerve Injuries 01/2021
1	Cerebral Infarction 01/2021
1	Hyperlipidemias (Hyperlipidemia) 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Disease Progression 01/2021
1	Epilepsy (Aura) 02/2020
1	Neurologic Manifestations (Neurological Manifestations) 01/2020
1	Brain Infarction 01/2020
1	Paraganglioma (Paragangliomas) 01/2020

Drug/Important Bio-Agent (IBA)

18	Complement System Proteins (Complement)IBA 01/2021 - 01/2006
7	Neuroprotective AgentsIBA 04/2015 - 08/2006
5	Tissue Plasminogen Activator (Alteplase)FDA Link 11/2021 - 08/2009
4	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 08/2009
4	AnaphylatoxinsIBA 12/2019 - 07/2006
3	complement C3a receptorIBA 10/2022 - 04/2019
3	AntioxidantsIBA 01/2022 - 08/2006
3	Anesthetics (Anesthetic Agents)IBA 01/2011 - 05/2007
3	Proteins (Proteins, Gene)FDA Link 05/2008 - 04/2006
2	Clopidogrel (Plavix)FDA Link 04/2022 - 09/2010
2	Oxygen (Dioxygen)IBA 01/2022 - 04/2019
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2019
2	Complement Inactivating AgentsIBA 01/2021 - 12/2007
2	Illicit Drugs (Recreational Drugs)IBA 01/2021 - 04/2010
2	Complement C3a (Complement 3a)IBA 01/2021 - 08/2007
2	Amobarbital (Amsal)IBA 02/2020 - 02/2018
2	SB 290157IBA 01/2020 - 04/2019
2	Vasopressins (Vasopressin)IBA 01/2017 - 03/2016
2	Matrix Metalloproteinase 9 (Gelatinase B)IBA 02/2016 - 10/2014
2	Anticonvulsants (Antiepileptic Drugs)IBA 01/2016 - 12/2009
2	LigandsIBA 07/2012 - 02/2009
2	Ascorbic Acid (Vitamin C)FDA LinkGeneric 09/2011 - 08/2006
2	Dehydroascorbic AcidIBA 09/2011 - 08/2006
2	Pharmaceutical PreparationsIBA 07/2010 - 10/2006
2	CalciumIBA 06/2008 - 05/2007
1	Omeprazole (Prilosec)FDA LinkGeneric 04/2022
1	LipidsIBA 01/2022
1	Pancreatic Elastase (Elastase)IBA 01/2021
1	Retinaldehyde (Retinal)IBA 01/2021
1	ElastinIBA 01/2021
1	Dihydrotachysterol (AT 10)IBA 05/2020
1	ethylene-vinyl alcohol copolymerIBA 01/2020
1	Interleukin-15 (Interleukin 15)IBA 01/2020

Therapy/Procedure

29	Therapeutics 04/2022 - 01/2006
14	Thrombectomy 01/2021 - 06/2015
11	Stents 04/2022 - 04/2014
6	Retreatment 10/2022 - 02/2017
3	Endovascular Procedures 10/2022 - 12/2012
3	Aftercare (After-Treatment) 12/2021 - 11/2014
3	Surgical Instruments (Clip) 12/2019 - 02/2017
3	Craniotomy 12/2019 - 12/2009
2	Length of Stay 04/2022 - 01/2021
2	Ischemic Postconditioning 01/2021 - 02/2015
2	Carotid Endarterectomy 01/2020 - 01/2006
2	Cerebral Revascularization 06/2008 - 05/2007
2	Deep Hypothermia Induced Circulatory Arrest 06/2008 - 05/2007
1	Lasers (Laser) 10/2022
1	Off-Label Use 01/2022
1	Ventriculoperitoneal Shunt 11/2021
1	Endarterectomy (Thromboendarterectomy) 01/2020